Showing posts with label contralateral breast cancer. Show all posts
Showing posts with label contralateral breast cancer. Show all posts

Tuesday, 2 April 2019

Risk factors for metachronous contralateral breast cancer: A systematic review and meta-analysis



by Delal Akdeniz, Marjanka K. Schmidt, Caroline M. Seynaeve, Danielle McCool, Daniele Giardiello, Alexandra J. van den Broek, Michael Hauptmann, Ewout W. Steyerberg, Maartje J. Hooning  

The Breast: April 2019, Volume 44, pages 1-14

The risk of developing metachronous contralateral breast cancer (CBC) is a recurrent topic at the outpatient clinic. We aimed to provide CBC risk estimates of published patient, pathological, and primary breast cancer (PBC) treatment-related factors.

Thursday, 17 May 2018

Incidence of isolated local breast cancer recurrence and contralateral breast cancer: A systematic review



by Inge Spronk, François G. Schellevis, Jako S. Burgers, Geertruida H. de Bock, Joke C. Korevaar  

The Breast: June 2018 Volume 39, Pages 70–79

An increasing number of women is surviving breast cancer and due to that at risk of developing an isolated ipsilateral breast tumor recurrence (IBTR) or a contralateral breast cancer (CBC). Patients' main concern is cancer recurrence. Patient counseling on breast cancer recurrence is challenging. In order to provide healthcare professionals and patients more guidance, a systematic literature review of the incidence of isolated IBTR and CBC in women diagnosed with early invasive breast cancer was performed.